APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Glucosylceramidase

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Glucosylceramidase Industry Growth and Trends Forecast to 2032

Report ID 173995700119 December 202598 pages

Choose your research edition.

Industry ResearchGlucosylceramidase Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Glucosylceramidase Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Glucosylceramidase Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Glucosylceramidase Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Glucosylceramidase Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Glucosylceramidase market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Glucosylceramidase is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Glucosylceramidase is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Glucosylceramidase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Glucosylceramidase include Takeda, The International Biotechnology Center (IBC) Generium, Protalix BioTherapeutics, Inc., Pharming Group N.V., JCR Pharmaceuticals Co., Ltd., greenovation Biotech GmbH, Bioorganic Research and Services S.A. and Amicus Therapeutics, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Glucosylceramidase market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Glucosylceramidase market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Glucosylceramidase market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Glucosylceramidase.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Glucosylceramidase market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Glucosylceramidase Market by Company

Takeda

The International Biotechnology Center (IBC) Generium

Protalix BioTherapeutics, Inc.

Pharming Group N.V.

JCR Pharmaceuticals Co., Ltd.

greenovation Biotech GmbH

Bioorganic Research and Services S.A.

Amicus Therapeutics, Inc.

Glucosylceramidase Segment by Type

Pcgin

NCGC-607

LTI-291

AVRRD-02

Others

Glucosylceramidase Segment by Application

Genetic Disorders

Parkinson's Disease

Gaucher Disease

Others

Glucosylceramidase Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glucosylceramidase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Glucosylceramidase and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glucosylceramidase.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Glucosylceramidase manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Glucosylceramidase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Pcgin Table 2. Major Company of NCGC-607 Table 3. Major Company of LTI-291 Table 4. Major Company of AVRRD-02 Table 5. Major Company of Others Table 6. Global Glucosylceramidase Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Glucosylceramidase Sales by Type (2021-2026) & (K Units) Table 8. Global Glucosylceramidase Sales Market Share in Volume by Type (2021-2026) Table 9. Global Glucosylceramidase Sales by Type (2021-2026) & (US$ Million) Table 10. Global Glucosylceramidase Sales Market Share in Value by Type (2021-2026) Table 11. Global Glucosylceramidase Price by Type (2021-2026) & (US$/Unit) Table 12. Global Glucosylceramidase Sales by Type (2027-2032) & (K Units) Table 13. Global Glucosylceramidase Sales Market Share in Volume by Type (2027-2032) Table 14. Global Glucosylceramidase Sales by Type (2027-2032) & (US$ Million) Table 15. Global Glucosylceramidase Sales Market Share in Value by Type (2027-2032) Table 16. Global Glucosylceramidase Price by Type (2027-2032) & (US$/Unit) Table 17. North America Glucosylceramidase Sales by Type (2021-2026) & (K Units) Table 18. North America Glucosylceramidase Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Glucosylceramidase Sales by Type (2021-2026) & (K Units) Table 20. Europe Glucosylceramidase Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Glucosylceramidase Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific Glucosylceramidase Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Glucosylceramidase Sales by Type (2021-2026) & (K Units) Table 24. Latin America Glucosylceramidase Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Glucosylceramidase Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa Glucosylceramidase Sales by Type (2021-2026) & (US$ Million) Table 27. Glucosylceramidase Industry Trends Table 28. Glucosylceramidase Industry Drivers Table 29. Glucosylceramidase Industry Opportunities and Challenges Table 30. Glucosylceramidase Industry Restraints Table 31. Global Glucosylceramidase Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Glucosylceramidase Revenue Market Share by Company (2021-2026) Table 33. Global Glucosylceramidase Sales by Company (2021-2026) & (K Units) Table 34. Global Glucosylceramidase Sales Share by Company (2021-2026) Table 35. Global Glucosylceramidase Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Glucosylceramidase Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Glucosylceramidase Major Company Production Sites and Headquarters Table 38. Global Glucosylceramidase Company, Product Type & Application Table 39. Global Glucosylceramidase Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Glucosylceramidase by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Glucosylceramidase Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Glucosylceramidase Sales by Region (2021-2026) & (K Units) Table 44. Global Glucosylceramidase Sales Market Share in Volume by Region (2021-2026) Table 45. Global Glucosylceramidase Sales by Region (2021-2026) & (US$ Million) Table 46. Global Glucosylceramidase Sales Market Share in Value by Region (2021-2026) Table 47. Global Glucosylceramidase Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Glucosylceramidase Sales by Region (2027-2032) & (K Units) Table 49. Global Glucosylceramidase Sales Market Share in Volume by Region (2027-2032) Table 50. Global Glucosylceramidase Sales by Region (2027-2032) & (US$ Million) Table 51. Global Glucosylceramidase Sales Market Share in Value by Region (2027-2032) Table 52. Global Glucosylceramidase Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Glucosylceramidase Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Glucosylceramidase Sales by Application (2021-2026) & (K Units) Table 55. Global Glucosylceramidase Sales Market Share in Volume by Application (2021-2026) Table 56. Global Glucosylceramidase Sales by Application (2021-2026) & (US$ Million) Table 57. Global Glucosylceramidase Sales Market Share in Value by Application (2021-2026) Table 58. Global Glucosylceramidase Price by Application (2021-2026) & (US$/Unit) Table 59. Global Glucosylceramidase Sales by Application (2027-2032) & (K Units) Table 60. Global Glucosylceramidase Sales Market Share in Volume by Application (2027-2032) Table 61. Global Glucosylceramidase Sales by Application (2027-2032) & (US$ Million) Table 62. Global Glucosylceramidase Sales Market Share in Value by Application (2027-2032) Table 63. Global Glucosylceramidase Price by Application (2027-2032) & (US$/Unit) Table 64. North America Glucosylceramidase Sales by Application (2021-2026) & (K Units) Table 65. North America Glucosylceramidase Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Glucosylceramidase Sales by Application (2021-2026) & (K Units) Table 67. Europe Glucosylceramidase Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Glucosylceramidase Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific Glucosylceramidase Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Glucosylceramidase Sales by Application (2021-2026) & (K Units) Table 71. Latin America Glucosylceramidase Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Glucosylceramidase Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa Glucosylceramidase Sales by Application (2021-2026) & (US$ Million) Table 74. Takeda Company Information Table 75. Takeda Business Overview Table 76. Takeda Glucosylceramidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Takeda Glucosylceramidase Product Portfolio Table 78. Takeda Recent Development Table 79. The International Biotechnology Center (IBC) Generium Company Information Table 80. The International Biotechnology Center (IBC) Generium Business Overview Table 81. The International Biotechnology Center (IBC) Generium Glucosylceramidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. The International Biotechnology Center (IBC) Generium Glucosylceramidase Product Portfolio Table 83. The International Biotechnology Center (IBC) Generium Recent Development Table 84. Protalix BioTherapeutics, Inc. Company Information Table 85. Protalix BioTherapeutics, Inc. Business Overview Table 86. Protalix BioTherapeutics, Inc. Glucosylceramidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Protalix BioTherapeutics, Inc. Glucosylceramidase Product Portfolio Table 88. Protalix BioTherapeutics, Inc. Recent Development Table 89. Pharming Group N.V. Company Information Table 90. Pharming Group N.V. Business Overview Table 91. Pharming Group N.V. Glucosylceramidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Pharming Group N.V. Glucosylceramidase Product Portfolio Table 93. Pharming Group N.V. Recent Development Table 94. JCR Pharmaceuticals Co., Ltd. Company Information Table 95. JCR Pharmaceuticals Co., Ltd. Business Overview Table 96. JCR Pharmaceuticals Co., Ltd. Glucosylceramidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. JCR Pharmaceuticals Co., Ltd. Glucosylceramidase Product Portfolio Table 98. JCR Pharmaceuticals Co., Ltd. Recent Development Table 99. greenovation Biotech GmbH Company Information Table 100. greenovation Biotech GmbH Business Overview Table 101. greenovation Biotech GmbH Glucosylceramidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. greenovation Biotech GmbH Glucosylceramidase Product Portfolio Table 103. greenovation Biotech GmbH Recent Development Table 104. Bioorganic Research and Services S.A. Company Information Table 105. Bioorganic Research and Services S.A. Business Overview Table 106. Bioorganic Research and Services S.A. Glucosylceramidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Bioorganic Research and Services S.A. Glucosylceramidase Product Portfolio Table 108. Bioorganic Research and Services S.A. Recent Development Table 109. Amicus Therapeutics, Inc. Company Information Table 110. Amicus Therapeutics, Inc. Business Overview Table 111. Amicus Therapeutics, Inc. Glucosylceramidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Amicus Therapeutics, Inc. Glucosylceramidase Product Portfolio Table 113. Amicus Therapeutics, Inc. Recent Development Table 114. North America Glucosylceramidase Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 115. North America Glucosylceramidase Sales by Country (2021-2026) & (K Units) Table 116. North America Glucosylceramidase Sales Market Share by Country (2021-2026) Table 117. North America Glucosylceramidase Sales Forecast by Country (2027-2032) & (K Units) Table 118. North America Glucosylceramidase Sales Market Share Forecast by Country (2027-2032) Table 119. North America Glucosylceramidase Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 120. North America Glucosylceramidase Market Size by Country (2021-2026) & (US$ Million) Table 121. North America Glucosylceramidase Market Share by Country (2021-2026) Table 122. North America Glucosylceramidase Market Size Forecast by Country (2027-2032) & (US$ Million) Table 123. North America Glucosylceramidase Market Share Forecast by Country (2027-2032) Table 124. Europe Glucosylceramidase Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 125. Europe Glucosylceramidase Sales by Country (2021-2026) & (K Units) Table 126. Europe Glucosylceramidase Sales Market Share by Country (2021-2026) Table 127. Europe Glucosylceramidase Sales Forecast by Country (2027-2032) & (K Units) Table 128. Europe Glucosylceramidase Sales Market Share Forecast by Country (2027-2032) Table 129. Europe Glucosylceramidase Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 130. Europe Glucosylceramidase Market Size by Country (2021-2026) & (US$ Million) Table 131. Europe Glucosylceramidase Market Share by Country (2021-2026) Table 132. Europe Glucosylceramidase Market Size Forecast by Country (2027-2032) & (US$ Million) Table 133. Europe Glucosylceramidase Market Share Forecast by Country (2027-2032) Table 134. Asia-Pacific Glucosylceramidase Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 135. Asia-Pacific Glucosylceramidase Sales by Country (2021-2026) & (K Units) Table 136. Asia-Pacific Glucosylceramidase Sales Market Share by Country (2021-2026) Table 137. Asia-Pacific Glucosylceramidase Sales Forecast by Country (2027-2032) & (K Units) Table 138. Asia-Pacific Glucosylceramidase Sales Market Share Forecast by Country (2027-2032) Table 139. Asia-Pacific Glucosylceramidase Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 140. Asia-Pacific Glucosylceramidase Market Size by Country (2021-2026) & (US$ Million) Table 141. Asia-Pacific Glucosylceramidase Market Share by Country (2021-2026) Table 142. Asia-Pacific Glucosylceramidase Market Size Forecast by Country (2027-2032) & (US$ Million) Table 143. Asia-Pacific Glucosylceramidase Market Share Forecast by Country (2027-2032) Table 144. Latin America Glucosylceramidase Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 145. Latin America Glucosylceramidase Sales by Country (2021-2026) & (K Units) Table 146. Latin America Glucosylceramidase Sales Market Share by Country (2021-2026) Table 147. Latin America Glucosylceramidase Sales Forecast by Country (2027-2032) & (K Units) Table 148. Latin America Glucosylceramidase Sales Market Share Forecast by Country (2027-2032) Table 149. Latin America Glucosylceramidase Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 150. Latin America Glucosylceramidase Market Size by Country (2021-2026) & (US$ Million) Table 151. Latin America Glucosylceramidase Market Share by Country (2021-2026) Table 152. Latin America Glucosylceramidase Market Size Forecast by Country (2027-2032) & (US$ Million) Table 153. Latin America Glucosylceramidase Market Share Forecast by Country (2027-2032) Table 154. Middle East and Africa Glucosylceramidase Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 155. Middle East and Africa Glucosylceramidase Sales by Country (2021-2026) & (K Units) Table 156. Middle East and Africa Glucosylceramidase Sales Market Share by Country (2021-2026) Table 157. Middle East and Africa Glucosylceramidase Sales Forecast by Country (2027-2032) & (K Units) Table 158. Middle East and Africa Glucosylceramidase Sales Market Share Forecast by Country (2027-2032) Table 159. Middle East and Africa Glucosylceramidase Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 160. Middle East and Africa Glucosylceramidase Market Size by Country (2021-2026) & (US$ Million) Table 161. Middle East and Africa Glucosylceramidase Market Share by Country (2021-2026) Table 162. Middle East and Africa Glucosylceramidase Market Size Forecast by Country (2027-2032) & (US$ Million) Table 163. Middle East and Africa Glucosylceramidase Market Share Forecast by Country (2027-2032) Table 164. Key Raw Materials Table 165. Raw Materials Key Suppliers Table 166. Glucosylceramidase Distributors List Table 167. Glucosylceramidase Customers List Table 168. Research Programs/Design for This Report Table 169. Authors List of This Report Table 170. Secondary Sources Table 171. Primary Sources List of Figures Figure 1. Glucosylceramidase Image Figure 2. Global Glucosylceramidase Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Glucosylceramidase Market Size (2021-2032) & (US$ Million) Figure 4. Global Glucosylceramidase Sales (2021-2032) & (K Units) Figure 5. Pcgin Image Figure 6. Global Pcgin Sales YoY Growth (2021-2032) & (K Units) Figure 7. NCGC-607 Image Figure 8. Global NCGC-607 Sales YoY Growth (2021-2032) & (K Units) Figure 9. LTI-291 Image Figure 10. Global LTI-291 Sales YoY Growth (2021-2032) & (K Units) Figure 11. AVRRD-02 Image Figure 12. Global AVRRD-02 Sales YoY Growth (2021-2032) & (K Units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global Glucosylceramidase Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Glucosylceramidase Market Share by Type 2025 VS 2032 Figure 17. North America Glucosylceramidase Sales Market Share in Volume by Type in 2025 Figure 18. North America Glucosylceramidase Sales Market Share in Value by Type in 2025 Figure 19. Europe Glucosylceramidase Sales Market Share in Volume by Type in 2025 Figure 20. Europe Glucosylceramidase Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Glucosylceramidase Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Glucosylceramidase Sales Market Share in Value by Type in 2025 Figure 23. Latin America Glucosylceramidase Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Glucosylceramidase Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Glucosylceramidase Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Glucosylceramidase Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Glucosylceramidase Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Genetic Disorders Image Figure 30. Global Genetic Disorders Sales YoY Growth (2021-2032) & (K Units) Figure 31. Parkinson's Disease Image Figure 32. Global Parkinson's Disease Sales YoY Growth (2021-2032) & (K Units) Figure 33. Gaucher Disease Image Figure 34. Global Gaucher Disease Sales YoY Growth (2021-2032) & (K Units) Figure 35. Others Image Figure 36. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 37. Global Glucosylceramidase Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Glucosylceramidase Market Share by Application 2025 VS 2032 Figure 39. North America Glucosylceramidase Sales Market Share in Volume by Application in 2025 Figure 40. North America Glucosylceramidase Sales Market Share in Value by Application in 2025 Figure 41. Europe Glucosylceramidase Sales Market Share in Volume by Application in 2025 Figure 42. Europe Glucosylceramidase Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Glucosylceramidase Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Glucosylceramidase Sales Market Share in Value by Application in 2025 Figure 45. Latin America Glucosylceramidase Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Glucosylceramidase Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Glucosylceramidase Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Glucosylceramidase Sales Market Share in Value by Application in 2025 Figure 49. North America Glucosylceramidase Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. North America Glucosylceramidase Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Glucosylceramidase Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Glucosylceramidase Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Glucosylceramidase Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Europe Glucosylceramidase Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Glucosylceramidase Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Glucosylceramidase Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Glucosylceramidase Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Asia-Pacific Glucosylceramidase Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Glucosylceramidase Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Glucosylceramidase Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Glucosylceramidase Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Latin America Glucosylceramidase Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Glucosylceramidase Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Glucosylceramidase Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Glucosylceramidase Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 66. Middle East and Africa Glucosylceramidase Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Glucosylceramidase Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Glucosylceramidase Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Glucosylceramidase Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Glucosylceramidase Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Pcgin
  • NCGC-607
  • LTI-291
  • AVRRD-02
  • Others
Applications
  • Genetic Disorders
  • Parkinson's Disease
  • Gaucher Disease
  • Others
Companies covered
  • Takeda
  • The International Biotechnology Center (IBC) Generium
  • Protalix BioTherapeutics, Inc.
  • Pharming Group N.V.
  • JCR Pharmaceuticals Co., Ltd.
  • greenovation Biotech GmbH
  • Bioorganic Research and Services S.A.
  • Amicus Therapeutics, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Glucosylceramidase Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Glucosylceramidase Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Glucosylceramidase Market by Type
  6. 1.3.1 Pcgin
  7. 1.3.2 NCGC-607
  8. 1.3.3 LTI-291
  9. 1.3.4 AVRRD-02
  10. 1.3.5 Others
  11. 1.4 Global Glucosylceramidase Market Size by Type
  12. 1.4.1 Global Glucosylceramidase Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Glucosylceramidase Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Glucosylceramidase Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Glucosylceramidase Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Glucosylceramidase Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Glucosylceramidase Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Glucosylceramidase Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Glucosylceramidase Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Glucosylceramidase Industry Trends
  2. 2.2 Glucosylceramidase Industry Drivers
  3. 2.3 Glucosylceramidase Industry Opportunities and Challenges
  4. 2.4 Glucosylceramidase Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Glucosylceramidase Revenue (2021-2026)
  2. 3.2 Global Top Players by Glucosylceramidase Sales (2021-2026)
  3. 3.3 Global Top Players by Glucosylceramidase Price (2021-2026)
  4. 3.4 Global Glucosylceramidase Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Glucosylceramidase Major Company Production Sites & Headquarters
  6. 3.6 Global Glucosylceramidase Company, Product Type & Application
  7. 3.7 Global Glucosylceramidase Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Glucosylceramidase Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Glucosylceramidase Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Glucosylceramidase Tier 1, Tier 2, and Tier 3
4 Glucosylceramidase Regional Status and Outlook
  1. 4.1 Global Glucosylceramidase Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Glucosylceramidase Historic Market Size by Region
  3. 4.2.1 Global Glucosylceramidase Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Glucosylceramidase Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Glucosylceramidase Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Glucosylceramidase Forecasted Market Size by Region
  7. 4.3.1 Global Glucosylceramidase Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Glucosylceramidase Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Glucosylceramidase Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Glucosylceramidase by Application
  1. 5.1 Glucosylceramidase Market by Application
  2. 5.1.1 Genetic Disorders
  3. 5.1.2 Parkinson's Disease
  4. 5.1.3 Gaucher Disease
  5. 5.1.4 Others
  6. 5.2 Global Glucosylceramidase Market Size by Application
  7. 5.2.1 Global Glucosylceramidase Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Glucosylceramidase Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Glucosylceramidase Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Glucosylceramidase Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Glucosylceramidase Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Glucosylceramidase Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Glucosylceramidase Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Glucosylceramidase Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Takeda
  2. 6.1.1 Takeda Company Information
  3. 6.1.2 Takeda Business Overview
  4. 6.1.3 Takeda Glucosylceramidase Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Glucosylceramidase Product Portfolio
  6. 6.1.5 Takeda Recent Developments
  7. 6.2 The International Biotechnology Center (IBC) Generium
  8. 6.2.1 The International Biotechnology Center (IBC) Generium Company Information
  9. 6.2.2 The International Biotechnology Center (IBC) Generium Business Overview
  10. 6.2.3 The International Biotechnology Center (IBC) Generium Glucosylceramidase Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 The International Biotechnology Center (IBC) Generium Glucosylceramidase Product Portfolio
  12. 6.2.5 The International Biotechnology Center (IBC) Generium Recent Developments
  13. 6.3 Protalix BioTherapeutics, Inc.
  14. 6.3.1 Protalix BioTherapeutics, Inc. Company Information
  15. 6.3.2 Protalix BioTherapeutics, Inc. Business Overview
  16. 6.3.3 Protalix BioTherapeutics, Inc. Glucosylceramidase Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Protalix BioTherapeutics, Inc. Glucosylceramidase Product Portfolio
  18. 6.3.5 Protalix BioTherapeutics, Inc. Recent Developments
  19. 6.4 Pharming Group N.V.
  20. 6.4.1 Pharming Group N.V. Company Information
  21. 6.4.2 Pharming Group N.V. Business Overview
  22. 6.4.3 Pharming Group N.V. Glucosylceramidase Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Pharming Group N.V. Glucosylceramidase Product Portfolio
  24. 6.4.5 Pharming Group N.V. Recent Developments
  25. 6.5 JCR Pharmaceuticals Co., Ltd.
  26. 6.5.1 JCR Pharmaceuticals Co., Ltd. Company Information
  27. 6.5.2 JCR Pharmaceuticals Co., Ltd. Business Overview
  28. 6.5.3 JCR Pharmaceuticals Co., Ltd. Glucosylceramidase Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 JCR Pharmaceuticals Co., Ltd. Glucosylceramidase Product Portfolio
  30. 6.5.5 JCR Pharmaceuticals Co., Ltd. Recent Developments
  31. 6.6 greenovation Biotech GmbH
  32. 6.6.1 greenovation Biotech GmbH Company Information
  33. 6.6.2 greenovation Biotech GmbH Business Overview
  34. 6.6.3 greenovation Biotech GmbH Glucosylceramidase Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 greenovation Biotech GmbH Glucosylceramidase Product Portfolio
  36. 6.6.5 greenovation Biotech GmbH Recent Developments
  37. 6.7 Bioorganic Research and Services S.A.
  38. 6.7.1 Bioorganic Research and Services S.A. Company Information
  39. 6.7.2 Bioorganic Research and Services S.A. Business Overview
  40. 6.7.3 Bioorganic Research and Services S.A. Glucosylceramidase Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Bioorganic Research and Services S.A. Glucosylceramidase Product Portfolio
  42. 6.7.5 Bioorganic Research and Services S.A. Recent Developments
  43. 6.8 Amicus Therapeutics, Inc.
  44. 6.8.1 Amicus Therapeutics, Inc. Company Information
  45. 6.8.2 Amicus Therapeutics, Inc. Business Overview
  46. 6.8.3 Amicus Therapeutics, Inc. Glucosylceramidase Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Amicus Therapeutics, Inc. Glucosylceramidase Product Portfolio
  48. 6.8.5 Amicus Therapeutics, Inc. Recent Developments
7 North America by Country
  1. 7.1 North America Glucosylceramidase Sales by Country
  2. 7.1.1 North America Glucosylceramidase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Glucosylceramidase Sales by Country (2021-2026)
  4. 7.1.3 North America Glucosylceramidase Sales Forecast by Country (2027-2032)
  5. 7.2 North America Glucosylceramidase Market Size by Country
  6. 7.2.1 North America Glucosylceramidase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Glucosylceramidase Market Size by Country (2021-2026)
  8. 7.2.3 North America Glucosylceramidase Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Glucosylceramidase Sales by Country
  2. 8.1.1 Europe Glucosylceramidase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Glucosylceramidase Sales by Country (2021-2026)
  4. 8.1.3 Europe Glucosylceramidase Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Glucosylceramidase Market Size by Country
  6. 8.2.1 Europe Glucosylceramidase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Glucosylceramidase Market Size by Country (2021-2026)
  8. 8.2.3 Europe Glucosylceramidase Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Glucosylceramidase Sales by Country
  2. 9.1.1 Asia-Pacific Glucosylceramidase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Glucosylceramidase Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Glucosylceramidase Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Glucosylceramidase Market Size by Country
  6. 9.2.1 Asia-Pacific Glucosylceramidase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Glucosylceramidase Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Glucosylceramidase Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Glucosylceramidase Sales by Country
  2. 10.1.1 South America Glucosylceramidase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Glucosylceramidase Sales by Country (2021-2026)
  4. 10.1.3 South America Glucosylceramidase Sales Forecast by Country (2027-2032)
  5. 10.2 South America Glucosylceramidase Market Size by Country
  6. 10.2.1 South America Glucosylceramidase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Glucosylceramidase Market Size by Country (2021-2026)
  8. 10.2.3 South America Glucosylceramidase Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Glucosylceramidase Sales by Country
  2. 11.1.1 Middle East and Africa Glucosylceramidase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Glucosylceramidase Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Glucosylceramidase Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Glucosylceramidase Market Size by Country
  6. 11.2.1 Middle East and Africa Glucosylceramidase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Glucosylceramidase Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Glucosylceramidase Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Glucosylceramidase Value Chain Analysis
  2. 12.1.1 Glucosylceramidase Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Glucosylceramidase Production Mode & Process
  7. 12.2 Glucosylceramidase Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Glucosylceramidase Distributors
  10. 12.2.3 Glucosylceramidase Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst